ESC 365 - Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI

ESC Premium Access

Bivalirudin versus UFH with or without GP IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary PCI

Session: Primary PCI

Topic: PCI: primary PCI / patient subsets

Speaker: Mr D. Venetsanos (Stockholm, SE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Mr Dimitris Venetsanos

Karolinska Institute, Stockholm (Sweden)

0 follower

4 more presentations in this session

State of the art in primary PCI.

Speaker: Professor D. Chew (Clayton, AU)

Healing course of coronary edge dissections after primary percutaneous coronary intervention with stent implantation assessed by intravascular ultrasound with iMap and optical coherence tomography

Speaker: Doctor M. Hougaard (Odense, DK)

Actuarial daily ischemic and bleeding risk after primary PCI for STEMI: insights from the HORIZONS-AMI trial

Speaker: Doctor G. Giustino (New York, US)

Future direction for research in primary PCI.

Speaker: Professor A. Kastrati (Munich, DE)

Access the full session

Primary PCI

Speakers: Mr D. Venetsanos, Professor D. Chew, Doctor M. Hougaard, Doctor G. Giustino, Professor A. Kastrati

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources